Document is current
Any future updates will be listed below
-
Authors
McCoy, Rozalina G. http://orcid.org/0000-0002-2289-3183
Campbell, Ronna L.
Mullan, Aidan F.
Bucks, Colin M.
Clements, Casey M.
Reichard, R. Ross
Jeffery, Molly M.
-
Funding
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (K23DK114497)
- License Information
-
More Information
Article History
Received: 19 May 2022
Accepted: 27 November 2022
First Online: 7 December 2022
Declarations
:
: Not applicable.
: This study was exempt from review by the Mayo Clinic Institutional Review Board because all subjects are deceased.
: In the last 36 months, RGM has received unrelated research support from NIDDK, PCORI, and AARP®. She also serves as a consultant to Emmi® (Wolters Kluwer) on the development of patient education materials related to prediabetes and diabetes. In the past 36 months, MMJ has received unrelated funding from the US Food and Drug Administration; the National Heart, Lung, and Blood Institute; the National Institute on Drug Abuse; the National Center for Advancing Translational Sciences; the Agency for Healthcare Research and Quality, and the American Cancer Society. Her spouse holds shares in Goodness Growth Holdings. CMC serves as a consultant to Vail Scientific for an area unrelated to this work (sepsis). RLC is an author for UpToDate and a consultant to Byrn Pharma for an area of unrelated to this work (anaphylaxis).
